Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations

Genes & Immunity volume 20, pages 455–461 (2019)Cite this article

Subjects

Abstract

The prognostic value of the systemic immune-inflammation index (SII) has been shown in various types of cancers. We aimed to evaluate the predictive values in brain metastases from lung adenocarcinoma with status of EGFR mutations. We, retrospectively, examined 310 patients with brain metastases from lung adenocarcinoma with status of EGFR mutations. SII was calculated using P * N/L, where P, N, and L, respectively refer to peripheral blood lymphocyte, neutrophil, and platelet counts. The cut-off value of SII was assessed by area under the curve (AUC). The log-rank test and Cox proportional hazard model were used to confirm the impact of SII and other variables on survival. The SII value ≤ 1218.81 was associated with prolonged survival in patients with brain metastases from lung adenocarcinoma in both variable and multivariable analysis In patients with EGFR mutations, the SII had statistical effect on OS only in invariable test. While, for patients with wild-type EGFR, SII achieved statistically significant differences both in variable and multivariable analyses. SII is an independent prognostic factor in brain metastases from lung adenocarcinoma. SII may have varying prognostic effects on patients with and without EGFR mutations and is a promising variable for the future prognostic systems.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973–2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22:2865–72.

    Article  Google Scholar 

  2. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors 316 in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–51.

    Article  CAS  Google Scholar 

  3. Chao ST, De Salles A, Hayashi M, Levivier M, Ma L, Martinez R, et al. Stereotactic radiosurgery in the management of limited (1–4) brain metasteses: systematic review and International Stereotactic Radiosurgery Society Practice Guideline. Neurosurgery. 2017;83:345–53.

    Article  Google Scholar 

  4. Jamal-Hanjani M, Spicer J. Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain. Clin Cancer Res. 2012;18:938–44.

    Article  CAS  Google Scholar 

  5. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors 316 in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–51.

    Article  CAS  Google Scholar 

  6. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70:510–4.

    Article  Google Scholar 

  7. Sperduto PW, Chao ST, Sneed PK, et al. Diagnosis specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4259 patients. Int J Radiat Oncol Biol Phys. 2010;77:655–61.

    Article  Google Scholar 

  8. Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212–22.

    Article  CAS  Google Scholar 

  9. Casadei Gardini A, Scarpi E, Faloppi L, Scartozzi M, Silvestris N, Santini D, et al. Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib. Oncotarget. 2016;7:67142–9.

    PubMed  Google Scholar 

  10. Fan L, Wang R, Chi C, Cai W, Zhang Y, Qian H, et al. Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients. Prostate. 2018;78:250–6.

    Article  CAS  Google Scholar 

  11. Huang L, Liu S, Lei Y, Wang K, Xu M, Chen Y, et al. Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection. Oncotarget. 2016;7:44185–93.

    PubMed  PubMed Central  Google Scholar 

  12. Hong X, Cui B, Wang M, Yang Z, Wang L, Xu Q. Systemic immune-inflammation index, based on platelet counts and neutrophil–lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J Exp Med. 2015;236:297–304.

    Article  CAS  Google Scholar 

  13. Cools-Lartigue J, Spicer J, McDonald B, Gowing S, Chow S, Giannias B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest. 2013;123:3446–58.

    Article  CAS  Google Scholar 

  14. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44.

    Article  CAS  Google Scholar 

  15. Zhou Y, Wei Q, Fan J, Cheng S, Ding W, Hua Z. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis containing 8252 patients. Clin Chim Acta. 2018;479:181–9.

    Article  CAS  Google Scholar 

  16. Yang JJ, Hu ZG, Shi WX, Deng T, He SQ, Yuan SG. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol. 2015;21:2807–15.

    Article  Google Scholar 

  17. Feng F, Tian Y, Liu S, Zheng G, Liu Z, Xu G. et al. Combination of PLR, MLR, MWR, and tumor size could significantly increase the prognostic value for gastrointestinal stromal tumors. Medicines. 2016;95:e3248

    Google Scholar 

  18. Yuan C, Li N, Mao X, Liu Z, Ou W, Wang SY. Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: results from a large cohort. Thorac Cancer. 2017;8:350–8.

    Article  CAS  Google Scholar 

  19. Sakurai K, Tamura T, Toyokawa T, Amano R, Kubo N, Tanaka H, et al. Low preoperative prognostic nutritional index predicts poor survival post-gastrectomy in elderly patients with gastric cancer. Ann Surg Oncol. 2016;23:3669–76.

    Article  Google Scholar 

  20. Yu J, Li SM, Kong Y, Si L, Sheng X, Chi Z, et al. Association of immune-inflammation index with outcome of high-risk acral melanoma patients treated with adjuvant highdose interferon. J Clin Oncol. 2016;34

    Article  Google Scholar 

  21. Lorenzoni J, Devriendt D, Massager N, et al. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys. 2004;60:218–24.

    Article  Google Scholar 

  22. Golden DW, Lamborn KR, McDermott MW, Kunwar S, Wara WM, Nakamura JL, et al. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site. J Neurosurg. 2008;109:77–86.

    Article  Google Scholar 

  23. deSouza NM, Liu Y, Chiti A, Oprea-Lager D, Gebhart G, Van Beers BE, et al. Strategies and technical challenges for imaging oligometastatic disease: recommendations from the European Organisation for Research and Treatment of Cancer imaging group. Eur J Cancer. 2018;91:153–63.

    Article  Google Scholar 

  24. Fink KR, Fink JR. Imaging of brain metastases. Surg Neurol Int. 2013;4(Suppl 4):S209–S19.

    Article  Google Scholar 

  25. Ando M, Ando Y, Hasegawa Y, Shimokata K, Minami H, Wakai K, et al. Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer. Br J Cancer. 2001;85:1634–9.

    Article  CAS  Google Scholar 

  26. Wang K, Diao F, Ye Z, Zhang X, Zhai E, Ren H, et al. Prognostic value of systemic immune-inflammation index in patients with gastric cancer. Chin J Cancer. 2017;36:75.

    Article  Google Scholar 

  27. Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15:425–30.

    Article  CAS  Google Scholar 

  28. Ngabire D, Kim GD. Autophagy and inflammatory response in the tumor microenvironment. Int J Mol Sci. 2017;18:2016.

    Article  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Radiation Oncology, Shanxi provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province, 030013, People’s Republic of China

      Hongwei Li, Guochao Wang, Xin Song, Jianzhong Cao, Xiaqin Zhang, Ruiqi Xue, Weili Wang, Sufang Jia & Zhengran Li

    2. Department of Medical Oncology, Shanxi provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi Province, 030013, People’s Republic of China

      Huanhu Zhang

    Authors
    1. Hongwei Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Guochao Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Huanhu Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Xin Song
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Jianzhong Cao
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Xiaqin Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Ruiqi Xue
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Weili Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Sufang Jia
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Zhengran Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Huanhu Zhang.

    Ethics declarations

    Conflict of interest

    The authors declare that they have no conflict of interest.

    Additional information

    These authors contributed equally: Hongwei Li, Guochao Wang

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Li, H., Wang, G., Zhang, H. et al. Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations. Genes Immun 20, 455–461 (2019). https://doi.org/10.1038/s41435-018-0050-z

    Download citation

    • Received:

    • Revised:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1038/s41435-018-0050-z

    This article is cited by

    Search

    Advanced search

    Quick links